Document Detail

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
MedLine Citation:
PMID:  21151176     Owner:  NLM     Status:  Publisher    
In contrast to other cytotoxic agents including anthracyclins and oxaliplatin (OXP), cisplatin (CDDP) fails to induce immunogenic tumor cell death that would allow to stimulate an anticancer immune response and hence to amplify its therapeutic efficacy. This failure to induce immunogenic cell death can be attributed to CDDP's incapacity to elicit the translocation of calreticulin (CRT) from the lumen of the endoplasmic reticulum (ER) to the cell surface. Here, we show that, in contrast to OXP, CDDP is unable to activate the protein kinase-like ER kinase (PERK)-dependent phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α). Accordingly, CDDP also failed to stimulate the formation of stress granules and macroautophagy, two processes that only occur after eIF2α phosphorylation. Using a screening method that monitors the voyage of CRT from the ER lumen to the cell surface, we identified thapsigargin (THAPS), an inhibitor of the sarco/ER Ca(2+)-ATPase as a molecule that on its own does not stimulate CRT exposure, yet endows CDDP with the capacity to do so. The combination of ER stress inducers (such as THAPS or tunicamycin) and CDDP effectively induced the translocation of CRT to the plasma membrane, as well as immunogenic cell death, although ER stress or CDDP alone was insufficient to induce CRT exposure and immunogenic cell death. Altogether, our results underscore the contribution of the ER stress response to the immunogenicity of cell death.Oncogene advance online publication, 13 December 2010; doi:10.1038/onc.2010.500.
I Martins; O Kepp; F Schlemmer; S Adjemian; M Tailler; S Shen; M Michaud; L Menger; A Gdoura; N Tajeddine; A Tesniere; L Zitvogel; G Kroemer
Related Documents :
22692046 - Concanavalin-a-induced autophagy biomarkers requires membrane type-1 matrix metalloprot...
21369706 - Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion...
4042456 - Attachment, spreading and growth in vitro of highly malignant and low malignant murine ...
1768216 - Thymoma with abundant l26-positive 'asteroid' cells. a case report with an analysis of ...
25070836 - Pi3k/mtor inhibition markedly potentiates hdac inhibitor activity in nhl cells through ...
20090526 - B cells in the pathogenesis and treatment of rheumatoid arthritis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-12-13
Journal Detail:
Title:  Oncogene     Volume:  -     ISSN:  1476-5594     ISO Abbreviation:  -     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
[1] INSERM, U848, Villejuif, France [2] Institut Gustave Roussy, Villejuif, France [3] Université Paris Sud-XI, Villejuif, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Apoptosis promotes early tumorigenesis.
Next Document:  Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease.